The June 2018 edition of The American Journal of Managed Care includes a longitudinal examination of the asthma medication ratio (AMR) of “a large national cohort of children with asthma.” Researchers calculated an AMR for each patient at rolling 3-month and 6-month periods, and classified patients as being at a low-risk, high-risk, or missing AMR. They then tested how those AMRs predicated “a child’s hospitalization or emergency department visit for asthma.” The researchers found “three-month AMR calculation periods appear to provide the most accurate assessment of risk.”
To view the article, click here.
